Cargando…
Lorcaserin therapy for severe epilepsy of childhood onset: A case series
Autores principales: | Tolete, Patricia, Knupp, Kelly, Karlovich, Michael, DeCarlo, Elaine, Bluvstein, Judith, Conway, Erin, Friedman, Daniel, Dugan, Patricia, Devinsky, Orrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207415/ https://www.ncbi.nlm.nih.gov/pubmed/30258026 http://dx.doi.org/10.1212/WNL.0000000000006432 |
Ejemplares similares
-
Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021) -
A case report on the efficacy of vigabatrin analogue (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms
por: Doumlele, Kyra, et al.
Publicado: (2016) -
Responsive neurostimulation targeting the anterior nucleus of the thalamus in 3 patients with treatment‐resistant multifocal epilepsy
por: Elder, Christopher, et al.
Publicado: (2019) -
SUDEP in patients with epilepsy and nonepileptic seizures
por: Verducci, Chloe, et al.
Publicado: (2019) -
Lorcaserin for weight management
por: Taylor, James R, et al.
Publicado: (2013)